Mr. Niall Conroy:

Part of the issue we saw there was around lower global demand generally. If these high level of tariffs were in situ in several countries, we could see lower levels of employment here in pharmaceuticals, but it did not have as big an impact as that seen in some other sectors. We think that is because those companies already have big investments here and large plants already operating here. As a result, there was a smaller impact than we had in some of the other sectors that are very global.